FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Original Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved Prasco Laboratories' original application for umeclidinium bromide and vilanterol Ellipta, a combined LAMA/LABA inhalation therapy for chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• UMECLIDINIUM AND VILANTEROL ELLIPTA (umeclidinium bromide and vilanterol triflate)

Snippet

ORIG AP for UMECLIDINIUM AND VILANTEROL ELLIPTA (UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE)